微导纳米：8月28日召开董事会会议

Group 1 - The company Micro导纳米 (SH 688147) announced its second board meeting on August 28, 2025, to review the 2025 semi-annual report and summary [1] - For the year 2024, the company's revenue composition is 99.85% from equipment manufacturing and 0.15% from other businesses [1] - As of the report, Micro导纳米 has a market capitalization of 20.4 billion yuan [1] Group 2 - The news highlights the successful transplantation of the world's first gene-edited pig lung into a human, raising questions about the timeline for clinical applications [1]